More recently, Roberts and colleagues reported that in individuals with CDH1 pathogenic variants identified by MultiGene Panel Testing (MGPT) who did not meet established clinical testing criteria, the cumulative incidence of GC at 80 years of age was significantly lower: 42% (95% confidence interval [CI], 30%–56%) for men and 33% (95%CI, 21%–43%) for women. Here, CDH1 is linked to gastric cancer.